Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
S47445 (formerly CX1632)
print preview
bookmark
share with colleague
General Information
Company
Cortex Pharmaceuticals Inc.
Description
Ampakine enhancer of the AMPA glutamate receptor
Molecular Target
AMPA glutamate receptor (GRIA) (GLUR)
Mechanism of Action
AMPA receptor enhancer
Latest Stage of Development
Phase I
Indication
Alzheimer's disease (AD)
Partner
Servier
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy